Levels of ras oncoproteins in human plasma from 1,3-bmtadiene-exposed workers and controls

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 349, Issue 1, 1996, Pages 115-120

  Anderson, D ^a   Hughes, J A ^a   Brinkworth, M H ^a   Peltonen, K ^b   Sorsa, M ^b  

^a BIBRA INTERNATIONAL   (United Kingdom)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

1,3 Butadiene; Occupational exposure; Oncoprotein; Ras

Indexed keywords

1,3 BUTADIENE; ONCOPROTEIN; RAS PROTEIN; STYRENE;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; GEL ELECTROPHORESIS; HUMAN; IMMUNOBLOTTING; MALE; OCCUPATIONAL EXPOSURE; PLASMA; PRIORITY JOURNAL; SMOKING HABIT;

ADULT; BUTADIENES; CARCINOGENS; HUMANS; MALE; OCCUPATIONAL EXPOSURE; RAS PROTEINS; STYRENE; STYRENES;

EID: 0030058139     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/0027-5107(95)00167-0     Document Type: Article

References (25)

1. Anderson, D., J.A. Hughes, A. Cebulska-Wasilewska, E. Nizankowska and B. Graca (1995) Ras oncoproteins in human plasma from lung cancer patients and healthy controls. Mutation Res., this issue.
2. Barbacid, M. (1987) Ras genes. Annu. Rev. Biochem., 56, 779-827.
3. Bishop, J.M. (1991) Molecular themes in oncogenesis. Cell, 64, 235-248.
4. Brandt-Rauf, P.W. (1988) New markers for monitoring occupational cancer: the example of oncogene proteins. J. Occup. Med., 30, 399-404.
5. Brandt-Rauf, P.W. (1991) Advances in cancer biomarkers as applied to chemical exposures: the ras oncogene and p21 protein and pulmonary carcinogenesis. J. Occup. Med., 33, 951-955.
6. Brandt-Rauf, P.W. and H.L. Niman (1988) Serum screening for oncogene proteins in workers exposed to PCBs. Br. J. Ind. Med., 45, 689-693.
7. Brandt-Rauf, P.W., S. Smith, H.L. Niman, M.D. Goldstein and E. Favata (1989) Serum oncogene proteins in hazardous waste workers. J. Soc. Occup. Med., 39, 141-143.
8. Brandt-Rauf, P.W., H.L. Niman and ST. Smith (1990a) Correlation between serum oncogene protein expression and the development of neoplastic disease in a worker exposed to carcinogens. J. R. Sec. Med., 83, 594-595.
9. Brandt-Rauf, P.W., S. Smith, F.P. Perera, H.L. Niman, W. Yohannan, K. Hemminki and R.M. Santella (1990b) Serum oncogene proteins in foundry workers. J. Soc. Occup. Med., 40, 11-14.
10. Brandt-Rauf, P.W., S. Smith, K. Hemminki, H. Koskinen and H. Vainio (1992) Serum oncoproteins and growth factors in asbestosis and silicosis patients, Int. J. Cancer, 50, 881-885.
11. Brinkworth, M.H., A. Yardley-Jones, A.J. Edwards, J.A. Hughes and D. Anderson (1992) A comparison of smokers and non smokers with respect to oncogene products and cytogenetic parameters. J. Occup. Med., 34, 1181-1188.
12. De Vivo, I., B. Breuer, S. Smith, C. Milling, M. Pincus, A.H. Tatum, J. Doucher, H.L. Niman, R. Minick, M. Osborne, D. Miller, H. Nowake Cody and P.W. Brandt-Rauf (1993) Detection of serum c-myc oncoprotein in cancer patients by immunoblot. Med. Sci. Res., 21, 345-347.
13. Finkelstein, S.D., R. Sayegh, S. Christensen and P.A. Swalsky (1993) Genotypic classification of colorectal adenocarcinoma: biologic behaviour correlates with K-ras-2 mutation type. Cancer, 71, 3827-3838.
14. Ford, J., S. Smith, J.-C. Luo, G. Friedmann-Jimenez, P. Brandt-Rauf, S. Markowitz, K. Garibaldi and H. Niman (1992) Serum growth factors and oncoproteins in firefighters. Occup. Med., 42, 39-42.
15. Frank, A.L. (1987) Occupational cancers of the respiratory system. Seinin. Occup. Med., 2, 257-266.
16. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680.
17. Luo, J.C. (1994) Detecting serum p53 in lung cancer patients. J. Occ. Med., 36, 155-160.
18. Lowry, O.H., N.J. Rosenbrough, A.L. Farr and R.J. Randall (1951) Protein measurement with Folin phenol reagent. J. Biol. Chem., 193, 265-275.
19. Malkin, D. (1994) Germline p53 gene mutations and cancer -Pandora's box or open sesame? J. Natl. Cane. Inst., 86, 326-328.
20. Niman, H.L., A.M.H. Thompson, M. Markman, J.J. Willems, K.R. Herwig, N.A. Habib, C.B. Wood, R.A. Houghten and R.A. Lerner (1985) Antipeptide antibodies detect oncogene-related proteins in urine. Proc. Natl. Acad. Sci. USA, 82, 7924-7928.
21. Perera, F.P., K. Hemminki, E. Gryzbowska, G. Motykiewicz, H. Michalska, R.M. Santella, T.L. Young, C. Dickey, P.W. Brandt-Rauf, I. DeVivo, W. Blaner, W.-Y. Tsai and M. Chorazy (1992) Molecular and genetic damage in humans from environmental pollution in Poland. Nature, 35, 256-258.
22. Pimental, E. (1989) Oncogenes, CRC, Boca Raton, FL.
23. Slebos, R.J.C., R.E. Kibberlaar, O. Dalesis, A. Kooistra, J. Stam, C.J.L.M. Meijer, S.S. Wagenaar, R.G.J.R.A. Van der Schueren, N. van Zandwijk, W.J. Mooi, J.L. Bos and S. Rodenhuis (1990) K-Ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. New Engl. J. Med., 323, 561-565.
24. Sorsa, M., K. Autio, N.A. Demopoulos, H. Jarventaus, P. Rossner, R.J. Šrám, S. Stepharou and D. Vlachodimitropoulos (1994) Human cytogenetic biomonitoring of occupational exposure to 1,3-butadiene. Mutation Res., 309, 321-327.
25. Towbin H., T. Staehelin and J. Gordon (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA, 76, 4350.